Production (Stage)
Tevogen Bio Holdings Inc.
TVGN
$1.31
$0.086.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.37M | -9.44M | -5.88M | -9.66M | 11.26M |
| Total Depreciation and Amortization | 105.40K | 103.50K | 101.70K | 100.00K | 98.30K |
| Total Amortization of Deferred Charges | -- | -800.00K | 0.00 | 0.00 | 800.00K |
| Total Other Non-Cash Items | 7.30M | 7.84M | 3.13M | 5.21M | -14.84M |
| Change in Net Operating Assets | -349.80K | -749.00K | -1.15M | 1.37M | 517.80K |
| Cash from Operations | -3.31M | -3.05M | -3.80M | -2.98M | -2.16M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 2.00M | 0.00 | 1.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.00M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 2.00M | 4.00M | 2.80M | 2.20M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | 229.30K |
| Cash from Financing | 4.00M | 2.00M | 5.00M | 2.80M | 2.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 691.90K | -1.05M | 1.20M | -182.50K | 265.50K |